Connect with us

Biotech

BioMarin’s Hemophilia a Gene Therapy Further Delayed Amid New FDA Questions

Elijah

Published

on

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Biotech

SKYLARK Sings: Sage, Biogen Hatch Positive Phase 3 Data in Postpartum Depression

Elijah

Published

on

By

SKYLARK sings: Sage, Biogen hatch positive phase 3 data in postpartum depression
ntaylor
Wed, 06/01/2022 – 07:39Read More

Original Post: fiercebiotech.com

Continue Reading

Biotech

Sanofi’s Hemlibra Rival Gets Step Closer to Approval With FDA Breakthrough Tag

Elijah

Published

on

Sanofi’s Hemlibra rival gets step closer to approval with FDA breakthrough tag
jwaldron
Wed, 06/01/2022 – 09:55Read More

Source: fiercebiotech.com

Continue Reading

Biotech

Amgen’s Heart Drug Reduces Cardiovascular Disease Risk Factor in Phase 2 Trial

Elijah

Published

on

Amgen’s heart drug reduces cardiovascular disease risk factor in phase 2 trial
aarmstrong
Wed, 06/01/2022 – 11:02Read More

Article: fiercebiotech.com

Continue Reading

Trending

EVU.io